Anti-Eotaxin-3 Antibody

This polyclonal reagent from Antibodies.com is raised in rabbit against human Eotaxin-3 (CCL26), a CC-chemokine ligand that acts through CCR3 to recruit eosinophils and basophils to sites of allergic inflammation. Researchers studying asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis use anti-CCL26 antibodies to probe epithelial and Th2-driven cytokine responses in patient-derived tissue, primary cell culture, and experimental models of airway inflammation. The unconjugated Ig fraction is supplied as 100 µL of polyclonal antiserum and is validated for Western blot and ELISA workflows against human samples, supporting studies of eotaxin family signaling and CCR3-mediated chemotaxis. Its polyclonal profile allows recognition of multiple epitopes on the CCL26 peptide, which is useful when mapping expression across different tissue compartments or comparing induced versus baseline chemokine levels. The reagent complements paired detection of related eosinophil-attracting chemokines such as CCL11 and CCL24, and it is intended for research use only, not for diagnostic or therapeutic application.